CN104436029A - Drug for treating pelvic inflammatory disease - Google Patents
Drug for treating pelvic inflammatory disease Download PDFInfo
- Publication number
- CN104436029A CN104436029A CN201410639535.3A CN201410639535A CN104436029A CN 104436029 A CN104436029 A CN 104436029A CN 201410639535 A CN201410639535 A CN 201410639535A CN 104436029 A CN104436029 A CN 104436029A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- fructus
- rhizoma
- fructus aurantii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Abstract
The invention provides a drug for treating pelvic inflammatory disease. The drug is characterized by comprising the following components in parts by weight: 10-12 parts of oldenlandia diffusa, 10-12 parts of honeysuckle, 10-12 parts of fructus forsythia, 10-12 parts of dandelion, 10-12 parts of cortex moutan, 10-12 parts of cortex phellodendri, 10-12 parts of semen plantaginis, 10-12 parts of hawthorns, 10-12 parts of peach kernels, 10-12 parts of patrinia, 10-12 parts of kelp, 10-12 parts of immature bitter orange, 10-12 parts of trigone, 10-12 parts of zedoary, 10-12 parts of fructus aurantii, 10-12 parts of rhizoma cyperi, 10-12 parts of frankincense, 10-12 parts of myrrh, 10-12 parts of dipsacus asperoides, 10-12 parts of angelica, 10-12 parts of akebiaquinata, 10-12 parts of asarum and 6-8 parts of licorice. The drug has the advantages of easiness for obtaining raw materials, low cost and significant treatment effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicinal formulae.
Background technology
Chinese medicine (Chinese herbology, Traditional Materia Medica), refers to the medicine of application under Han nationality's folk medicine instructs.Chinese medicine is divided into Chinese patent medicine, Chinese crude drug by processing technique.Chinese medicine is originating primarily from China, except plant amedica, animal drugs as Fel Serpentis, Fel Ursi, Agkistrodon, Cornu Cervi Pantotrichum, Cornu Cervi etc.; Shell class as Margarita, Concha Meretricis seu Cyclinae; Mineral substance is as Os Draconis, and Magnetitum etc. are all used to the Chinese medicine of curing the disease.Minority Chinese medicine comes from foreign country, as Radix Panacis Quinquefolii.China working people, for thousands of years in the process combated the disease, by practice, is constantly familiar with, have accumulated abundant medicinal knowledge gradually.Because word in period in romote antiquity is not emerging, these knowledge can only rely on transmission from master to disciple oral instruction, have had word afterwards, and have just recorded gradually, and occurred medical book.These books serve sums up forefathers' experience and is convenient to the effect spreading and promote.Chinese medicine has the history of thousands of years, and be that the very rich experience that Chinese people struggle with disease is for a long time summed up, the prosperity for the Chinese nation has huge contribution.Because medicine medium-height grass class is in the great majority, so the books recording medicine are just called " book on Chinese herbal medicine ".According to textual criticism, when Qin Han, book on Chinese herbal medicine is popular more, but these books on Chinese herbal medicine are lost all unfortunately, can not investigate.The herbal the earliest works now known is called Shennong's Herbal, pandect is totally three volumes, record medicine comprise dynamic, plant, ore deposit three class, totally 365 kinds, every medicine item is downloaded to be had nature and flavor, function and cures mainly, and another example in order describes the basic theories of medication briefly, as toxicity or no toxicity, four natures and five flavors of drug, compatibility law, method of administration and ball, fall apart, the dosage form such as cream, wine, can say it is the summary of China's knowledge of medication before the Chinese, and lay a good foundation for later pharmaceutical development.Greatest works in China's book on Chinese herbal medicine history, achievement extremely brilliant in the history of science of Ye Shi China.Now affecting larger is " Dictionary of Chinese Pharmacy " that nineteen thirty-five Chen Cunren writes.Pandect 2,700,000 word, receive 4300, medicine order, every medicine is introduced name, ancient books another name, basic, the place of production, form, character, composition, usefulness respectively, cured mainly, successive dynasties description textual criticism, discrimination, person of modern times's theory, fit applications, consumption, use compatibility and incompatibility of drugs, reference material etc. 21.Abundant information, comprehensively, summarize relevant discussion at all times, and drawings attached.It is first large-scale dictionary on Traditional Chinese Medicine Phylogeny.Maybe about 7,000 hundred million will be reached to Chinese herbal medicine industry total industrial output value in 2015.
Through general retrieval, do not find the scheme identical with present patent application.
Summary of the invention
The object of the invention is to: propose one and treat acute pelvic inflammatory disease medicine.
Treatment acute pelvic inflammatory disease medicine of the present invention, it is characterized in that: by weight, by Herba Hedyotidis Diffusae 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Taraxaci 10-12 parts, Cortex Moutan 10-12 parts, Cortex Phellodendri 10-12 parts, Semen Plantaginis 10-12 parts, Fructus Crataegi 10-12 parts, 10-12 parts, Semen Persicae, Herba Patriniae 10-12 parts, Thallus Laminariae (Thallus Eckloniae) 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, Rhizoma Sparganii 10-12 parts, Rhizoma Curcumae 10-12 parts, Fructus Aurantii 10-12 parts, Rhizoma Cyperi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Radix Dipsaci 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Caulis Akebiae 10-12 parts, Herba Asari 10-12 parts, 6-8 parts, Radix Glycyrrhizae composition.
Treatment acute pelvic inflammatory disease medicine of the present invention, it is characterized in that: by weight, by Herba Hedyotidis Diffusae 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Taraxaci 10-12 parts, Cortex Moutan 10-12 parts, Cortex Phellodendri 10-12 parts, Semen Plantaginis 10-12 parts, Fructus Crataegi 10-12 parts, 10-12 parts, Semen Persicae, Herba Patriniae 10-12 parts, Thallus Laminariae (Thallus Eckloniae) 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, Rhizoma Sparganii 10-12 parts, Rhizoma Curcumae 10-12 parts, Fructus Aurantii 10-12 parts, Rhizoma Cyperi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Radix Dipsaci 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Caulis Akebiae 10-12 parts, Herba Asari 10-12 parts, 6-8 parts, Radix Glycyrrhizae composition, pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, point 3 decoction being taken warmly, every day 1 dose.
Treatment acute pelvic inflammatory disease medicine of the present invention, it is characterized in that: by weight, by Herba Hedyotidis Diffusae 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Taraxaci 10-12 parts, Cortex Moutan 10-12 parts, Cortex Phellodendri 10-12 parts, Semen Plantaginis 10-12 parts, Fructus Crataegi 10-12 parts, 10-12 parts, Semen Persicae, Herba Patriniae 10-12 parts, Thallus Laminariae (Thallus Eckloniae) 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, Rhizoma Sparganii 10-12 parts, Rhizoma Curcumae 10-12 parts, Fructus Aurantii 10-12 parts, Rhizoma Cyperi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Radix Dipsaci 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Caulis Akebiae 10-12 parts, Herba Asari 10-12 parts, 6-8 parts, Radix Glycyrrhizae composition, adopt the method for prior art to extract active ingredient, make powdered granule product.
Treatment acute pelvic inflammatory disease medicine of the present invention, it is characterized in that: by weight, by Herba Hedyotidis Diffusae 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Taraxaci 10-12 parts, Cortex Moutan 10-12 parts, Cortex Phellodendri 10-12 parts, Semen Plantaginis 10-12 parts, Fructus Crataegi 10-12 parts, 10-12 parts, Semen Persicae, Herba Patriniae 10-12 parts, Thallus Laminariae (Thallus Eckloniae) 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, Rhizoma Sparganii 10-12 parts, Rhizoma Curcumae 10-12 parts, Fructus Aurantii 10-12 parts, Rhizoma Cyperi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Radix Dipsaci 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Caulis Akebiae 10-12 parts, Herba Asari 10-12 parts, 6-8 parts, Radix Glycyrrhizae composition, adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
The present invention has the following advantages and effect: the advantages such as it has raw material and is easy to get, and cost is low, and therapeutic effect is remarkable.
Detailed description of the invention
Below in conjunction with test and clinical trial situation, technical scheme of the present invention is described in further detail.
Treatment acute pelvic inflammatory disease medicine of the present invention, it is characterized in that: by weight, by Herba Hedyotidis Diffusae 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Taraxaci 10-12 parts, Cortex Moutan 10-12 parts, Cortex Phellodendri 10-12 parts, Semen Plantaginis 10-12 parts, Fructus Crataegi 10-12 parts, 10-12 parts, Semen Persicae, Herba Patriniae 10-12 parts, Thallus Laminariae (Thallus Eckloniae) 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, Rhizoma Sparganii 10-12 parts, Rhizoma Curcumae 10-12 parts, Fructus Aurantii 10-12 parts, Rhizoma Cyperi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Radix Dipsaci 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Caulis Akebiae 10-12 parts, Herba Asari 10-12 parts, 6-8 parts, Radix Glycyrrhizae composition, pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, point 3 decoction being taken warmly, every day 1 dose.
Chinese medicinal formulae of the present invention is proved recipe handed down from one's ancestors, in the past few decades, has treated many patients, has now enumerated model case as follows:
Model case clinical effectiveness:
Lin, female, 33 years old.Lower abdomen pain falling inflation more than 3 years, before 3 years, got ring, the time is longer, postoperative sense hypogastralgia, pudendum falling inflation, and lumbosacral region is ached, and belt transect of bleeding, once used antibiotic therapy, and symptom has no improvement.Gynecologial examination has inflammatory mass, and B ultrasonic shows endometritis, and through examining: irregular menstrual period, the few color of amount is dim, pale tongue with white fur, deep-slow pulse.Take treatment acute pelvic inflammatory disease medicine of the present invention 5 days, hypogastric region and perineum pain falling inflation alleviate, and the few color of leukorrhagia amount is white.Continue to take treatment acute pelvic inflammatory disease medicine of the present invention 15 days, hypogastric region and perineum pain falling inflation disappear, and menstrual period are normal.Gynecologial examination, inflammatory mass disappears, B ultrasonic check uterus no abnormality seen.
5 certain, female, 35 years old.Lower abdomen pain falling inflation more than 1 year, pudendum falling inflation, lumbosacral region is ached, and belt transect of bleeding, once used antibiotic therapy, and symptom has no improvement.Gynecologial examination has inflammatory mass, and B ultrasonic shows endometritis.Take treatment acute pelvic inflammatory disease medicine of the present invention 3 days, hypogastric region and perineum pain falling inflation alleviate.Continue to take treatment acute pelvic inflammatory disease medicine of the present invention 12 days, hypogastric region and perineum pain falling inflation disappear, and menstrual period are normal.Gynecologial examination, inflammatory mass disappears, B ultrasonic check uterus no abnormality seen.
Claims (4)
1. a treatment acute pelvic inflammatory disease medicine, it is characterized in that: by weight, by Herba Hedyotidis Diffusae 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Taraxaci 10-12 parts, Cortex Moutan 10-12 parts, Cortex Phellodendri 10-12 parts, Semen Plantaginis 10-12 parts, Fructus Crataegi 10-12 parts, 10-12 parts, Semen Persicae, Herba Patriniae 10-12 parts, Thallus Laminariae (Thallus Eckloniae) 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, Rhizoma Sparganii 10-12 parts, Rhizoma Curcumae 10-12 parts, Fructus Aurantii 10-12 parts, Rhizoma Cyperi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Radix Dipsaci 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Caulis Akebiae 10-12 parts, Herba Asari 10-12 parts, 6-8 parts, Radix Glycyrrhizae composition.
2. a treatment acute pelvic inflammatory disease medicine, it is characterized in that: by weight, by Herba Hedyotidis Diffusae 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Taraxaci 10-12 parts, Cortex Moutan 10-12 parts, Cortex Phellodendri 10-12 parts, Semen Plantaginis 10-12 parts, Fructus Crataegi 10-12 parts, 10-12 parts, Semen Persicae, Herba Patriniae 10-12 parts, Thallus Laminariae (Thallus Eckloniae) 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, Rhizoma Sparganii 10-12 parts, Rhizoma Curcumae 10-12 parts, Fructus Aurantii 10-12 parts, Rhizoma Cyperi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Radix Dipsaci 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Caulis Akebiae 10-12 parts, Herba Asari 10-12 parts, 6-8 parts, Radix Glycyrrhizae composition, pulverize, packaging, obtains product.
3. a treatment acute pelvic inflammatory disease medicine, it is characterized in that: by weight, by Herba Hedyotidis Diffusae 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Taraxaci 10-12 parts, Cortex Moutan 10-12 parts, Cortex Phellodendri 10-12 parts, Semen Plantaginis 10-12 parts, Fructus Crataegi 10-12 parts, 10-12 parts, Semen Persicae, Herba Patriniae 10-12 parts, Thallus Laminariae (Thallus Eckloniae) 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, Rhizoma Sparganii 10-12 parts, Rhizoma Curcumae 10-12 parts, Fructus Aurantii 10-12 parts, Rhizoma Cyperi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Radix Dipsaci 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Caulis Akebiae 10-12 parts, Herba Asari 10-12 parts, 6-8 parts, Radix Glycyrrhizae composition, adopt the method for prior art to extract active ingredient, make powdered granule product.
4. a treatment acute pelvic inflammatory disease medicine, it is characterized in that: by weight, by Herba Hedyotidis Diffusae 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Taraxaci 10-12 parts, Cortex Moutan 10-12 parts, Cortex Phellodendri 10-12 parts, Semen Plantaginis 10-12 parts, Fructus Crataegi 10-12 parts, 10-12 parts, Semen Persicae, Herba Patriniae 10-12 parts, Thallus Laminariae (Thallus Eckloniae) 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, Rhizoma Sparganii 10-12 parts, Rhizoma Curcumae 10-12 parts, Fructus Aurantii 10-12 parts, Rhizoma Cyperi 10-12 parts, Olibanum 10-12 parts, Myrrha 10-12 parts, Radix Dipsaci 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Caulis Akebiae 10-12 parts, Herba Asari 10-12 parts, 6-8 parts, Radix Glycyrrhizae composition, adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410639535.3A CN104436029A (en) | 2014-11-13 | 2014-11-13 | Drug for treating pelvic inflammatory disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410639535.3A CN104436029A (en) | 2014-11-13 | 2014-11-13 | Drug for treating pelvic inflammatory disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104436029A true CN104436029A (en) | 2015-03-25 |
Family
ID=52883290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410639535.3A Pending CN104436029A (en) | 2014-11-13 | 2014-11-13 | Drug for treating pelvic inflammatory disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104436029A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105288506A (en) * | 2015-12-03 | 2016-02-03 | 苏州枫灵医药科技有限公司 | Pharmaceutical preparation for treating acute pelvic inflammatory disease |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536888A (en) * | 2013-10-31 | 2014-01-29 | 金占荣 | Medicine for treating chronic pelvic inflammation and preparation method of same |
CN103800746A (en) * | 2014-03-18 | 2014-05-21 | 黄淑娟 | Traditional Chinese medicine composition for treating acute pelvic inflammation |
CN103800843A (en) * | 2014-03-18 | 2014-05-21 | 黄淑娟 | Traditional Chinese medicine composition for treating chronic pelvic inflammation |
-
2014
- 2014-11-13 CN CN201410639535.3A patent/CN104436029A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103536888A (en) * | 2013-10-31 | 2014-01-29 | 金占荣 | Medicine for treating chronic pelvic inflammation and preparation method of same |
CN103800746A (en) * | 2014-03-18 | 2014-05-21 | 黄淑娟 | Traditional Chinese medicine composition for treating acute pelvic inflammation |
CN103800843A (en) * | 2014-03-18 | 2014-05-21 | 黄淑娟 | Traditional Chinese medicine composition for treating chronic pelvic inflammation |
Non-Patent Citations (1)
Title |
---|
陆晓红: "中医治疗盆腔炎的研究进展", 《天津中医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105288506A (en) * | 2015-12-03 | 2016-02-03 | 苏州枫灵医药科技有限公司 | Pharmaceutical preparation for treating acute pelvic inflammatory disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101653590B (en) | Medicine for treating habitual abortion and preparation method thereof | |
CN103751497A (en) | Medicament for treating mastitis and preparation method thereof | |
CN104435424A (en) | Medicine for treating male climacteric syndrome | |
CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
CN103845417A (en) | Chinese herbal granule used for relieving pain caused by sudden sprain in lumbar region | |
CN104435252A (en) | Medicine for treating acute mastitis | |
CN102988591A (en) | Pure Chinese medicine preparation for treating astriction | |
CN104383486A (en) | Medicament for treating bronchitis of children | |
CN104435567A (en) | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout | |
CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
CN104367888A (en) | Medicine for treating acute and chronic balanitis | |
CN104367949A (en) | Medicament for treating urinary calculus | |
CN104367951A (en) | Medicine for treating prostate hyperplasia | |
CN104383485A (en) | Medicine for treating infantile anorexia | |
CN104436029A (en) | Drug for treating pelvic inflammatory disease | |
CN104383046A (en) | Medicament for treating infantile diarrhea | |
CN101254256A (en) | Clearing blood nourishing heart powder | |
CN104367730A (en) | Medicine for treating postpartum urinary retention | |
CN104435079A (en) | Traditional Chinese medicinal composition for treating gout | |
CN104435350A (en) | Drug for treating functional uterine bleeding | |
CN104367777A (en) | Medicine for treating spermatorrhea | |
CN104435313A (en) | Medicine for treating haemorrhoids | |
CN103142839A (en) | Chinese herbal medicine prescription for treating impotence and premature ejaculation | |
CN104435264A (en) | Medicine for treating intestine obstruction | |
CN104474377A (en) | Medicine for treating rheumatoid arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |
|
RJ01 | Rejection of invention patent application after publication |